1-12 of 12
Xiaoqi Qin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

High Risk Cytogenetic Abnormalities Are Poor Prognostic Factors for Newly Diagnosed Multiple Myeloma Patients Received Autologous Hematopoietic Cell Transplantation

Chuanying Geng, Jing Lu, Xiaozhe Li, Qiang Li, Na Li, Weiwei Tian, Jie Zhao, Guangzhong Yang, Yanping Ma, Xiaoqi Qin, Jing Jia, Huixing Zhou, Lintao Bi, Chenchen Wang, Ying Sun, Xiantao Liu, Yuan Jian, Qingming Wang, Haixiang Wan, Jinqiao Zhang, Han Liu, Hui Geng, Xiaojing Ma, Yunxia Liang, Rui Hu, Da Gao, Donghai Han, Haisheng Liu, Guangyu Ma, Zhihua Zhang, Wei Wang, Shi Minxia, Bo Nie, Zhang Hong, Jie Li, Guitao Jie, Meiying Fan, Qinglin Song, Wenyong Li, Zhenfang Xi, Guorong Gao, Jie Liu, Zhihua Li, Hua Xue, Huimei Guo, Jie Li, Xiaohan Gao, Guo-Hong Su, Jie Shen, ARong Jin, Peng Lv, Wenming Chen, Juan Li, Juan Du, Wen Gao
Journal: Blood
Blood (2024) 144 (Supplement 1): 6925.
https://doi.org/10.1182/blood-2024-205155
Published: 2024
Journal Articles

Carfilzomib, Pomalidomide, Dexamethasone with and without Daratumumab in Relapsed/Refractory Multiple Myeloma: A Multi-Center, Prospective Real World Study in China

Fujing Zhang, Wei Wang, Hua Wang, Wei Wang, Aijun Liu, Weiwei Tian, Xiaoqi Qin, Zhongjun Xia, Junling Zhuang
Journal: Blood
Blood (2024) 144 (Supplement 1): 6985.
https://doi.org/10.1182/blood-2024-209342
Published: 2024
Journal Articles

Ixazomib, Pomalidomide and Dexamethasone (IxaPD) Pan-Oral Regimen in the Treatment of Refractory and Relapsed Multiple Myeloma

Miao Chen, Hong Yu, Aijun Liu, Wei Wang, Xiaoqi Qin, Ziping Li, Yanping Ma, Wenming Chen, Rong Fu, Junling Zhuang
Journal: Blood
Blood (2024) 144 (Supplement 1): 7038.
https://doi.org/10.1182/blood-2024-210284
Published: 2024
Journal Articles

Clonal Heterogeneity and Evolutionary Phylogeny of Critical Cytogenetic Aberrations in Multiple Myeloma

Yuting Yan, Xiaoqi Qin, Jiahui Liu, Huishou Fan, Lanting Liu, Zhen Yu, Shuhui Deng, Wei Liu, Dehui Zou, Lugui Qiu, Gang An
Journal: Blood
Blood (2021) 138 (Supplement 1): 1608.
https://doi.org/10.1182/blood-2021-152794
Published: 2021
Journal Articles

Clonal Phylogeny and Evolution of Critical Cytogenetic Aberrations in Multiple Myeloma at Single Cell Level

Yuting Yan, Xiaoqi Qin, Lanting Liu, Shuhui Deng, MD, Jiahui Liu, Huishou Fan, Weiwei Sui, MD, Fu Mingwei, MD, Xue-Han Mao, MD, Zhen Yu, MD, Dehui Zou, MD, Lugui Qiu, MD, Gang An, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 43–44.
https://doi.org/10.1182/blood-2020-143447
Published: 2020
Journal Articles

Suppression of Cdc37 Induces BTZ Resistance through XBP1s Mediated Plasma Cell Immaturation in Multiple Myeloma

Meirong Zang, Lanting LIU, Fengyan Jin, Jiaojiao Guo, An Gang, MD, Xiaoqi Qin, Tao Zhu, Shuhui Deng, Zhang Shuaishuai, MD, Mu Hao, PhD, Xiaoyan Feng, Yan Xu, MD, Wen Zhou, Lugui Qiu, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4350.
https://doi.org/10.1182/blood.V130.Suppl_1.4350.4350
Published: 2017
Journal Articles

Suppression of Cdc37 Induces Bortezomib Resistance through Autophagy Activation and Plasma Cell Immaturation in Multiple Myeloma

Meirong Zang, Fengyan Jin, Lanting Liu, Gang An, MDPhD, Xiaoqi Qin, MD, Xiaoyan Feng, Yan Xu, MDPhD, Mu Hao, MD PhD, Wen Zhou, PhD, Lugui Qiu, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2480.
https://doi.org/10.1182/blood.V126.23.2480.2480
Published: 2015
Journal Articles

Clonal Evolution Paths Significantly Impact the Outcome of Myeloma

Xiaoqi Qin, MD, Gang An, MDPhD, Lin-ping Hu, MD, Yu Qin, MD PhD, Yan Xu, MDPhD, Xiaoyan Feng, Meirong Zang, Shuhui Deng, MD PhD, Weiwei Sui, MD, Shuhua Yi, MD PhD, Zengjun Li, Sr., Lin-hua Yang, MD, Tao Cheng, MD, Jianxiang Wang, MD, Lugui Qiu, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1784.
https://doi.org/10.1182/blood.V126.23.1784.1784
Published: 2015
Journal Articles

Voriconazole Increase the Risk of PN in Multiple Myeloma Patients Treated with Bortezomib-Based Chemotherapy

Yan Xu, MDPhD, Shuhui Deng, MD, Gang An, MDPhD, Zengjun Li, Sr., Xiaoqi Qin, MD, Weiwei Sui, MD, Xiaoyan Feng, Dehui Zou, Lugui Qiu, MD PhD
Journal: Blood
Blood (2015) 126 (23): 5394.
https://doi.org/10.1182/blood.V126.23.5394.5394
Published: 2015
Journal Articles

Clonal Heterogeneityand Evolutional Paths in Multiple Myeloma Revealed By QM-FISH in Single Cell of Sequential Analysis

Xiaoqi Qin, Gang An, MD PhD, Yu Qin, PhD, Yan Xu, MD PhD, Xiaoyan Feng, MD, Meirong Zang, PhD, Weiwei Sui, MD, Shuhui Deng, MD, Shuhua Yi, Wen Zhou, PhD, Lugui Qiu, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3395.
https://doi.org/10.1182/blood.V124.21.3395.3395
Published: 2014
Journal Articles

MiR-137 Contributes to Drug Susceptibility and Chromosomal Instability of Multiple Myeloma through Targeting AURKA

Yu Qin, PhD, Fei Li, MD, Xiaoqi Qin, Gang An, MD PhD, Mu Hao, PhD, Meirong Zang, PhD, Yan Xu, MD PhD, Wen Zhou, PhD, Hong Chang, Lugui Qiu, MD
Journal: Blood
Blood (2014) 124 (21): 5715.
https://doi.org/10.1182/blood.V124.21.5715.5715
Published: 2014
Journal Articles

Unmeasurable Serum M-Protein Multiple Myeloma Benefit Less from Bortezomib Than Measurable Myeloma

Xiaoqi Qin, Gang An, MD PhD, Yan Xu, MD PhD, Yu Qin, PhD, Xiaoyan Feng, MD, Meirong Zang, PhD, Weiwei Sui, MD, Shuhui Deng, MD, Shuhua Yi, Wen Zhou, PhD, Lugui Qiu, MD
Journal: Blood
Blood (2014) 124 (21): 2062.
https://doi.org/10.1182/blood.V124.21.2062.2062
Published: 2014